Stimcell Energetics (STME) Receivables - Other (2020 - 2022)

Stimcell Energetics (STME) posted quarterly Receivables - Other of $2650.0 for Q1 2022, down 23.74% quarter-over-quarter from $3475.0 in Q4 2021.

Stimcell Energetics (STME) Receivables - Other (2020 - 2022) Analysis & Trends

Stimcell Energetics' Receivables - Other history runs 3 years deep, the most recent figure standing at $2650.0 for Q1 2022.

In Q1 2022, Receivables - Other changed N/A year-over-year to $2650.0; the TTM figure through Feb 2022 stood at $2650.0 (changed N/A YoY), while the FY2021 annual figure was $3682.0, changed N/A from the prior year.
Receivables - Other for Q1 2022 stood at $2650.0, down from $3475.0 in the prior quarter.
The five-year high for Receivables - Other was $3682.0 in Q2 2021, with the low at $2650.0 in Q1 2022.
The 3-year median for Receivables - Other is $3449.5 (2020), against an average of $3330.3.
Peak annual rise in Receivables - Other reached 9.14% in 2021, while the deepest fall reached 1.49% in 2021.
Stimcell Energetics' Receivables - Other stood at $3424.0 in 2020, then climbed by 1.49% to $3475.0 in 2021, then fell by 23.74% to $2650.0 in 2022.
Business Quant data shows STME's Receivables - Other at $2650.0 in Q1 2022, $3475.0 in Q4 2021, and $3523.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Stimcell Energetics	4.65 Mn	4.64 Mn	-

Download Data